Search research articles
Contact Us
Filters
Showing results (121-130 of 376) with videos related to
Page
of 38
Sort By:
Eye (London, England)
|
October 18, 2019
Ophthalmic biosimilars and biologics-role of endotoxins
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
April 11, 2019
Biotherapeutics and immunogenicity: ophthalmic perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
September 19, 2019
Brolucizumab: is extended VEGF suppression on the horizon?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Retina (Philadelphia, Pa.)
|
September 20, 2012
Retinal toxicity of intravitreal rituximab in albino rabbits
Zohar Habot-Wilner, Jonathan Shahar, Esther Zemel, et al.
Eye (London, England)
|
March 9, 2019
Biologics, biosilimars, and biobetters: different terms or different drugs?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
European Journal of Ophthalmology
|
March 23, 2010
Comparison of the transpalpebral tonometer TGDc-01 with Goldmann applanation tonometry
Michael Waisbourd, Gabi Shemesh, Lea Baras Top, et al.
Retina (Philadelphia, Pa.)
|
July 16, 2008
Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits
Izabela Komarowska, Gad Heilweil, Philip J Rosenfeld, et al.
Journal of Vitreoretinal Diseases
|
November 17, 2023
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
March 24, 2020
Pediatric Publication Trends in Leading General Ophthalmology Journals for 20 Years
Ari Leshno, Chaim Stolovitch, Adiel Barak, et al.
The British Journal of Ophthalmology
|
July 19, 2019
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 376) with videos related to
Sort By:
Page
of 38
Eye (London, England)
|
October 18, 2019
Ophthalmic biosimilars and biologics-role of endotoxins
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
April 11, 2019
Biotherapeutics and immunogenicity: ophthalmic perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
September 19, 2019
Brolucizumab: is extended VEGF suppression on the horizon?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Retina (Philadelphia, Pa.)
|
September 20, 2012
Retinal toxicity of intravitreal rituximab in albino rabbits
Zohar Habot-Wilner, Jonathan Shahar, Esther Zemel, et al.
Eye (London, England)
|
March 9, 2019
Biologics, biosilimars, and biobetters: different terms or different drugs?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
European Journal of Ophthalmology
|
March 23, 2010
Comparison of the transpalpebral tonometer TGDc-01 with Goldmann applanation tonometry
Michael Waisbourd, Gabi Shemesh, Lea Baras Top, et al.
Retina (Philadelphia, Pa.)
|
July 16, 2008
Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits
Izabela Komarowska, Gad Heilweil, Philip J Rosenfeld, et al.
Journal of Vitreoretinal Diseases
|
November 17, 2023
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
March 24, 2020
Pediatric Publication Trends in Leading General Ophthalmology Journals for 20 Years
Ari Leshno, Chaim Stolovitch, Adiel Barak, et al.
The British Journal of Ophthalmology
|
July 19, 2019
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Page
of 38